Changes in the ,-adrenergic receptor-G protein-adenylate cyclase complex were investigated in an experimental canine model of low-output heart failure produced by chronic rapid ventricular pacing. The contractile response occurring after exposure to the P-adrenergic agonist dobutamine, measured as peak left ventricular +dP/dt, was decreased after 3 weeks of pacing. To further characterize the diminished functional responsiveness to 3-adrenergic receptor stimulation, ,3-adrenergic receptor-adenylate cyclase coupling was investigated using membranes prepared from both control and paced animals. The density of J3-adrenergic receptors was decreased by 40% with a selective downregulation of the P3-subtype. The affinity of the receptor for the antagonist radioligand [1251]iodocyanopindolol remained unchanged. A defect in coupling was suggested by a decreased ability of isoproterenol, fluoride, and forskolin to stimulate adenylate cyclase in membranes prepared from failing hearts. Determination of the levels of Gia (the a-subunit of G;) by immunoblotting and pertussis toxin labeling revealed modest increases of -30%. Furthermore, Mn2' and purified G, failed to stimulate adenylate cyclase in membranes prepared from failing hearts, indicating an impairment in the catalytic moiety of adenylate cyclase itself or in the ability of adenylate cyclase to couple to G,. In contrast, complementation assay did not reveal differences in the functional activity of Q. (the a-subunit of Gs). Taken together, these data demonstrate a selective decrease in the P,/-subtype of adrenergic receptors and an increase in a 40-kd Gi-like protein in the failing heart. Similar changes have been described in human idiopathic dilated cardiomyopathy. In addition to these changes, we identified a possible defect at the level of the catalytic subunit of adenylate cyclase.
/3-adrenergic receptor, which binds the stimulatory hormone; the catalytic moiety of adenylate cyclase, which synthesizes cAMP from ATP; and the stimulatory guanine nucleotide-binding regulatory protein (Gb), which couples the ,B-adrenergic receptor to its effector.
The decreased response to ,3-adrenergic stimulation in the failing human heart results in part from downregulation of 83-adrenergic receptors. Bristow et all described a selective decrease in the density of l31-receptors in failing human heart, as well as a significant impairment in the development of contractile force in response to the ,3-agonists isoproterenol and dobutamine.4,5 Additional abnormalities distal to the receptor may also be responsible for reduced cAMP production during f-adrenergic stimulation. 6 For example, an increase in the level and/or function of the inhibitory G protein Gi, which antag-onizes the action of Gs, has been observed in humans and in animal models of heart failure. 7, 8 Studies of the 18-adrenergic complex in experimental models of heart failure have revealed divergent results compared with the changes seen in idiopathic heart failure in humans. Studies by Vatner et a12 and Longabaugh et a19 in a canine model of heart failure due to left ventricular (LV) pressure overload revealed an increased density of /3-receptors associated with a decrease in Gs. In a guinea pig model of heart failure, Karliner et al10 also showed an increase in the density of /3-receptors. In contrast, a canine model of right heart failure revealed a decrease in the density of /3-receptors restricted to the right ventricle." Furthermore, studies of the cardiomyopathic Syrian hamster revealed a functionally abnormal G, in the presence of unchanged /8-receptor density. 3 The diverse abnormalities in signal transduction in various animal models may arise from the different pathogenic mechanisms for the various forms of heart failure. Although these models remain useful for studying signal transduction, the availability of an animal model with changes in the 3-adrenergic complex similar to those found in human idiopathic cardiomyopathy remains desirable.
The purpose of the present study was to characterize the P-adrenergic receptor-adenylate cyclase system in an experimental canine model of heart failure produced by chronic rapid ventricular pacing. Results of several studies from this laboratory and elsewhere have shown that rapid ventricular pacing of dog hearts at 240-260 beats/min results in lowoutput heart failure characterized by biventricular pump dysfunction and dilation, as well as hemodynamic changes similar to those observed in human biventricular dysfunction.12
Materials and Methods Animals
Twenty-two adult mongrel dogs weighing 18-25 kg were studied during the course of the present investigation. An initial set of experiments was performed on 14 (six paced and eight sham-operated) dogs. The dogs were preanesthetized with atropine (0.5 mg) and morphine sulfate (10 mg) and were anesthetized with sodium pentobarbital (10 mg/kg) and morphine sulfate (8 mg/kg). Through a left lateral thoracotomy, epicardial pacing leads were sutured onto the LV apex. The leads were tunneled to the back and connected to a multiprogrammable pulse generator (Medtronic Inc., Minneapolis, Minn.) implanted subcutaneously. After recovery from anesthesia, the dogs were returned to a chronic care facility. Two days later, the pacemaker was programmed to 260 beats/min in six dogs; eight dogs remained nonpaced and served as controls. At 4 weeks, blood was obtained at rest to measure plasma levels of norepinephrine and epinephrine. After the fourth week of pacing, dogs were anesthetized with morphine sulfate (4-6 mg/kg) and chloralose (75 mg/kg) and intu-bated. A continuous infusion of chloralose was initiated at 10 mg/kg/hr. A Swan-Ganz catheter was inserted into the external jugular vein and positioned in the pulmonary artery. Five minutes later, the following hemodynamic measurements were recorded: right atrial pressure, pulmonary artery pressure, pulmonary capillary wedge pressure, cardiac output, and arterial pressure. Cardiac output was measured in triplicate by thermodilution. Dogs were then killed with an overdose of sodium pentobarbital (50 mg/kg).
A separate set of studies was performed on four different dogs to assess the cardiac responses to /3-adrenergic stimulation with dobutamine. The study was designed such that each dog would serve as its own control. Pacemaker implantation was performed as described above. To avoid early postoperative effects on adrenergic responsiveness, the dogs were given 7 days to recover, at which time a baseline hemodynamic assessment was performed. Dogs were anesthetized with sodium pentobarbital and valium, intubated, and maintained on a ventilator (Harvard Apparatus, South Natick, Mass.) with anesthesia maintained using intravenous morphine given as a 2-4 mg bolus every 20 minutes. Arterial pH was maintained between 7.35 and 7.45 by altering respiratory rate. A Swan-Ganz catheter was inserted through an external jugular vein and a SF micromanometer-tipped catheter (Millar Instruments, Houston, Tex.) was inserted via a femoral artery and placed in the LV. A side-arm sheath (Cordis) in the right femoral artery was used to monitor arterial pressure. LV pressure was calibrated against a mercury manometer and against the arterial pressure measurements. Hemodynamic measurements were obtained at paced heart rates of 150 beats/min by reprogramming the permanent pacemaker. After placement of catheters, baseline hemodynamic measurements were taken and then averaged from two consecutive sets of data separated by at least 10 minutes and differing by < 10%. Hemodynamic measurements and peak LV +dP/dt (by continuous electronic differentiation) were recorded both on paper and on FM magnetic tape for subsequent data analysis. Baseline hemodynamic data were obtained during continuous infusion of 5% dextrose in water (D5W) using a Harvard pump at a rate of 1.9 ml/min. Dobutamine diluted in D5W was then infused at 5-minute intervals according to the following schedule: 2.5, 5.0, 7.5, 10.0, and 15.0 ,gg/kg/min. Hemodynamic measurements were made during the fifth minute of each infusion period. At the termination of the study, pacing was discontinued, femoral arteries were repaired, and the dogs were allowed to recover from anesthesia and were returned to a chronic-care facility. Two days later, rapid ventricular pacing was initiated by programming pacemakers to 260 beats/ min. After 3 weeks, the same protocol used in obtaining hemodynamic measurements and LV +dP/dt responses to dobutamine infusion was repeated. Rapid ventricular pacing was resumed 2 days into recovery. One week later, at the end of the fourth week of rapid pacing, the dogs were killed with an intravenous overdose of pentobarbital (50 mg/kg), and LV tissue was obtained. Four noninstrumented dogs were killed simultaneously, and LV tissue was removed to serve as control samples. The tissue samples obtained from the eight dogs of this latter set of studies (four paced and four control) were used only for studies of pertussis toxin-catalyzed ribosylation and of adenylate cyclase stimulation by Mn'4.
Membrane Preparation
After the dogs were killed, the hearts were immediately excised, and the LV free wall was removed and placed in buffer containing the following components at 4°C: 50 mM Tris-HCl (pH 7.4), 1 mM MgCl2, 1 mM EDTA, 20 ,ug/ml leupeptin, and 32 gg/ml lima bean trypsin inhibitor. Cardiac tissue was minced and homogenized with a Polytron tissue disrupter (Brinkmann Instruments, Inc., Westbury, N.Y.) for 10 seconds. The homogenate was filtered through sterile cheesecloth and centrifuged at 1,00(g for 5 minutes. The supernatant was recentrifuged at 18,000g for 15 minutes, and the pellet was resuspended in buffer.
The homogenization and centrifugation were repeated twice. The pellet was resuspended in a protein concentration of 3 mg/ml and stored at -70°C until assayed. Adenylate cyclase activity was stable (±+9%) over 3 months of storage; receptor binding was stable (±6%) over 6 months of storage. 
Binding of Dihydropyridine
The density of binding sites for dihydropyridine was determined using [3H]PN-200-110 (Amersham Corp., Arlington Heights, Ill.) as previously described.'6 Crude membranes were incubated at 37°C for 30 minutes with increasing concentrations of [3H]PN-200-110. Specific binding was defined as binding inhibited by 10 ,uM nifedipine, and binding parameters were determined by the method of Scatchard.
Adenylate Cyclase Assay
Adenylate cyclase activity was determined in crude cardiac membranes (50-100 gug) by measuring the conversion of [a-'P]ATP to cyclic [a-YP]AMP as described previously.'718 cAMP formed during the reaction was isolated by the method of Salomon et al. 19 Basal activity in the presence of 10 ,uM GTP was used to assess the net basal activity of both Gi and G, on adenylate cyclase activity in control and failing membranes before the addition of specific agonists.
Labeling of Gia by ADP-Ribosylation With Pertussis Toxin
Pertussis toxin-mediated ["P]ADP-ribosylation was performed on membranes prepared from LV tissue immediately after excision of four paced hearts and four control canine hearts. Tissue was placed in buffer containing the following components at 4°C: 50 mM Tris-HCI (pH 7.4), 1 mM MgCI2, 1 mM EGTA, 1 mM EDTA, 20 ,g/ml leupeptin, and 32 1ug/ml lima bean trypsin inhibitor. Tissue was homogenized with a Dounce homogenizer, filtered through cheesecloth, and spun for 15 minutes at 30,000g in a Sorvall centrifuge, and the supernatant was discarded. The pellet was resuspended in the same buffer, homogenized, and refiltered through cheesecloth. ["2P]ADPribosylation of G proteins was carried out at 37°C for 40 minutes on membrane homogenates as previously described.20,2' The assay mixture contained: 0.01 mM NAD, 2 ,LCi [32P]NADW, 2.5 mM ATP, 2 mM GTP, 10 mM isoniazid, 10 mM thymidine, 5 mM MgCl2, 20 ,ug/ml pertussis toxin, 10 mM phosphocreatine, 0.84 IU creatine phosphokinase, and 100-200 gg tissue in a total volume of 50 gl. The reaction was stopped by the addition of 2% sodium dodecyl sulfate in sample buffer followed by boiling for 2 minutes and sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Equal amounts of protein were placed in each lane. Analysis of the protein bands after ADP-ribosylation was performed on 11% polyacrylamide gels. Dry gels were exposed to Kodak film with enhancing screens for 2-3 days at -70°C. The autoradiograms from the dried gels were scanned on a densitometer, and the labeled 40-kd band representing the Gia (the a-subunit of Gi) was cut out and weighed. The weights obtained represent the relative levels of Gi,.
Reconstitution of G, in Cyc-Membranes
Reconstitution of adenylate cyclase in membranes prepared from cyc mouse S49 lymphoma cells was performed according to the methods of Sternweis et al,22 as previously described. 23 Heart membranes (2.5 mg/ml) were solubilized in buffer containing 10 mM Tris, 10 mM MgCl1, 0.1 mM EDTA, 1 mM dithiothreitol, and 0.2% Lubrol for 60 minutes at room temperature. After centrifugation at 20,00(, the supernatant was heated at 30°C for 10 minutes; the extract was then (25, 50 , and 100 jug) and cyc-membranes (60 jug) were incubated for 20 minutes at 30°C with 10 ,uM NaF. Enzyme-Linked Immunotransfer Blotting Rabbit peptide-directed antibodies against a defined region of Gia were raised as previously described (antiserum 1398).24 The antibodies were not specific and could recognize Gia1, Gi,2, Gi. 3, and Goa.
The antiserum against GO (antiserum 5357) was generated by immunization with Gp purified from bovine brain. Antiserum 5357 does contain some reactivity toward GiQ and Goa, but it is negligible at the concentration used. In addition, the antiserum that recognizes Gi, does not produce overlapping signals in the 35-kd region in our laboratory's experience with various cell tissues. Immunoblotting was carried out as previously described. 23 Briefly, after transfer of proteins from sodium dodecyl sulfatepolyacrylamide gels, cardiac membranes were suspended in 20 mM Tris-HCl and 500 mM NaCl (TBS), then with 3% gelatin in TBS for 30 minutes. Membranes were incubated with a 1:100 dilution of antiserum in 1% gelatin in TBS for 2 hours, washed twice in TBS containing 0.05% Tween 20, then incubated with a 1:2,000 dilution of goat anti-rabbit immunoglobulin G conjugated to horseradish peroxidase for 1-3 hours. Membranes were washed twice in TBS/0.05% Tween 20 and placed in TBS containing 0.5 mg/ml of 4-chloro-1-naphthol and 0.015% H202. Color development was allowed to occur for 10-20 minutes and was terminated by washing membranes in distilled water. The intensity of the developed color was a linear function of the amount of membrane protein subjected to these procedures.
Stimulation With Purified Gsa
Purification of G, from rabbit liver was accomplished as described by Sternweis et al. 22 Purified GTP-y-S-activated G, was prepared by incubation of Gs (40 gug/ml) for 60 minutes in a solution containing 2 ,uM GTP-y-S, 30 mM MgCl2, 0.1 mM EDTA, 0.1 mM dithiothreitol, 25 mM NaCl, and 0.1% Lubrol PX. Activated GS was added to membranes by dilu-tion into the reaction mixture for assay of adenylate cyclase as previously described.24
Plasma Catecholamines and Protein Assays
Plasma catecholamine levels were measured after high-pressure liquid chromatography as described by Goldstein et al. 25 Protein concentration was measured by the method of Lowry et a126 using bovine serum albumin as a standard.
Statistical Analysis
All values are expressed as mean±SEM. Statistical evaluation was performed by Student's t test. Serial changes within each group were analyzed by repeated-measures analysis of variance. A probability value of p<0.05 was considered statistically significant.
Results

Baseline Hemodynamic Studies
After 4 weeks of ventricular pacing at 260 beats/ min, all dogs had hemodynamic evidence of biventricular heart failure. Right atrial pressure was increased (14±1 mm Hg in dogs with heart failure versus 3 ± 1 mm Hg in control dogs) as were pulmonary capillary wedge pressure (24±2 versus 2±1 mm Hg) and LV end-diastolic pressure (19±3 versus 7±1 mm Hg, Table 1 ). The cardiac output in paced dogs was markedly reduced (1.5±0.1 1/min in dogs with heart failure versus 3.2±0.5 1/min in control dogs) (allp<0.01). LV +dP/dt was obtained on four dogs in the baseline state and after 3 weeks of pacing.
Resting peak LV +dP/dt decreased from 2,122±185 to 1,322±103 mm Hg/sec (p<0.01) ( Table 1) .
Effect of Dobutamine Infusion on +dP/dt
The effect of dobutamine infusion on peak LV +dP/dt was assessed. To control for changes in heart rate responses, hemodynamics were obtained at fixed heart rates of 150 beats/min. The significantly impaired contractile response was reflected by the percent increase in peak LV + dP/dt in the failing dogs compared with the baseline state (Table 1, Figure 1 ). Graph showing effect of dobutamine on percent increase in peak left ventricular +dP/dt. CHF, congestive heart failure. The percent increase in peak left ventricular +dPldt during dobutamine infusion in four dogs was measured before and after 3 Identification and Quantification of /3Pand f32-Adrenergic Populations ICI 89,406, a selective /31-competitive antagonist, was used to determine the relative percentage of 831and f32-adrenergic receptors. A representative set of ICI 89,406-ICYP competition curves is given in Figure 2 .5 Table 2 gives the summary of the density of ,81-and 132-receptors for the competition curves in all the paced and control LV membranes, and demonstrates the decrease in 131-receptor density and unchanged density 
Binding of Dihydropyridine
The density of binding sites for dihydropyridines has been shown in human idiopathic dilated cardiomyopathy not to change significantly compared with normal values and thus was used as a reference marker in the present study.27 The density of binding sites from paced hearts (128±+15 fmol/mg protein) was not significantly different from that of control hearts (113± 12 fmol/mg protein) (p=NS), suggesting that the alterations in the density of 1-receptors were not related to alterations in the membrane preparation. Crude membranes (30 gg of protein) were incubated with a 1:1,000 dilution of antisera as described in "Materials and Methods" in six control (C) and six heart failure (H) dogs. A single gel of four control and four heart failure dogs is shown.
tory protein, was measured by 1) enzyme-linked immunotransfer blotting (Western blot) and 2) pertussis toxin-dependent ADP-ribosylation. The functional activity of Gsa (the a-subunit of Gs) was measured by the ability of detergent extracts of cardiac membranes to reconstitute adenylate cyclase activity in cyc-S49 mouse lymphoma cell membranes.
Enzyme-Linked Immunotransfer Blotting of G,,
To measure relative amounts of Gia. or G1-subunits in cardiac membranes, enzyme-linked immunotransfer blotting was performed using antibodies from polyclonal antiserum raised against Gi, and the fl-subunit ( Figure 3 ). Results of densitometric analysis suggested that there was a modest increase in Gia (34+8%) in membranes from the failing ventricles (n=6) compared with control ventricles (n=6). There was no significant difference in the level of the fl-subunit between control and failing membranes. Pertussis Toxin -Catalyzed /32PJADP-Ribosylation Pertussis toxin catalyzes the incorporation of j7P]ADP-ribose from NAD to the a-subunit of Gi, which can be identified on autoradiography as a major peptide band of 40 kd.7 Equal amounts of control and heart failure membranes were labeled in the presence of pertussis toxin and [32P]NAD+ to measure relative amounts of GQ,. Pertussis toxinmediated [32P]ADP-ribosylation was performed on membranes prepared from freshly excised heart tissue obtained from four control and four heart failure dogs. The relative amount of [32P]ADP-ribose incorporated into the 40-kd pertussis toxin substrate was quantified by densitometry. Membranes from failing ventricles had 28+12% more Gia, (n=4, p<0.05) compared with control membranes (Figure 4 ).
Reconstitution of G,
Activity of G, was assessed using a reconstitution assay in which the ability of detergent extracts of cardiac membranes to reconstitute adenylate cyclase activity was studied.22 Cyc cells have the catalytic unit of adenylate cyclase but are deficient in functional GS and thus have no measurable activity until reconstituted with Gs. solubilized from sarcolemmal membranes.28 Reconstitution of fluoride-stimulated adenylate cyclase activity was a linear function of the amount of extract from both control and failing hearts ( Figure 5 ). There was no difference in the reconstituting activity of extracts from control and paced hearts, suggesting that there were no significant changes in functional Gs, in failing dogs. Equivalent amounts of G. were also suggested in experiments involving radiolabeling with [2P]NAD' and cholera toxin (data not shown).
Adenylate Cyclase Assay
Adenylate cyclase activity was measured in membranes from control and failing hearts to assess coupling between the fl-adrenergic receptor and adenylate cyclase ( Table 3 ). Basal adenylate cyclase (with GTP) was reduced by 27% in failing LV tissue (p<0.05) when compared with control tissue. Failing ventricles had a 60% reduction in net maximal isoproterenol-stimulated adenylate cyclase activity compared with control ventricles. Fluoride is a selective activator of GQ, and forskolin potentiates the activation of the catalytic moiety of adenylate cyclase by Gs, respectively.29-32 Sodium fluoride (10 mM)and forskolin (30 ,uM) -stimulated adenylate cyclase activities (without GTP) were reduced 40% and 49%, respectively, in failing myocardium compared with control myocardium. To further investigate a potential defect in the catalytic subunit, Mn21 (10 mM)-stimulated adenylate cyclase activity in membranes prepared from normal and failing hearts was studied. Mn2'stimulated adenylate cyclase activity was significantly less than that observed in the normal myocardium (201.5+7.8 pmol cAMP/mg/min in heart failure dogs versus 257.7+27.2 pmol cAMP/mg/min in control dogs, n=4,p-0.01).
The functional integrity of adenylate cyclase was additionally assessed by measuring activities elicited with purified GTP-y-S-activated G,. A marked enhancement of activities for membranes from both control and failing hearts was observed ( Figure 6 ). Homogenates were prepared and incubated for 40 minutes at 37°C with pertussis toxin and [32PJNADt solubilized, and subjected to polyacrylamide gel electrophoresis and autoradiography as described under "Materials and Methods." Equal amounts of protein were placed in each lane as determined by the method of Lowry.26 adenylate cyclase in this model of experimental heart failure.
In a separate set of experiments, the possibility that alterations in adenylate cyclase activity resulted from the presence of a nonspecific inhibitor of adenylate cyclase was investigated. Membrane from failing hearts was incubated in a ratio of 1: 1 with control membrane. Forskolin (30 gM)-stimulated adenylate cyclase activity in the 1:1 mixture was not statistically different from the sum of the forskolin-stimulated activities of control and failed LV membranes when determined separately (p=NS). Discussion A canine model of low-output heart failure induced by chronic rapid ventricular pacing has been used for more than 20 years. 33 Results of prior studies have shown that this model produces a preparation that is similar both hemodynamically and neurohormonally to human dilated cardiomyopathy.'2,34 Typical manifestations of heart failure in this model include ascites, pulmonary edema, reduced cardiac output, as well as elevated right atrial, pulmonary capillary wedge, and LV end-diastolic pressures. The levels of plasma renin, angiotensin IL, aldosterone, vasopressin, atrial natriuretic factor, norepinephrine. and epinephrine are increased as in the failing human heart.3536 Biventricular cardiac dilation and dysfunction and markedly impaired LV contractile function can be detected echocardiographically after 2 weeks of rapid pacing. However, biochemical abnormalities associated with or underlying the hemodynamic derangements seen in this model of heart failure are not understood. Specifically, it is not clear whether a potential defect in the J3-adrenergic receptor-effector coupling resides at the level of the /3-receptor or the level distal to the receptor or both. The present results show that the canine pacing model of heart failure is associated with diminished f-adrenergic responsiveness, a decreased density of /3-adrenergic receptors, and postreceptor defects in signal transduction, including changes in G proteins and a possible defect in adenylate cyclase.
The failing heart shows a diminished responsiveness to /3-adrenergic stimulation. This is in part the result of /3-receptor downregulation. Fowler et a14
and Bristow et a15 demonstrated in failing human hearts a selective decrease in the f1-subpopulation of receptors as well as a diminished contractile response to /3-agonists. Although unchanged in density, stimulatory responses mediated by ,B-adrenergic receptors are also impaired, suggesting an uncoupling from distal effector mechanisms.5 Postreceptor defects in signal transduction have also been observed in the failing myocardium. The coupling mechanisms distal to the surface-membrane P-receptor include the catalytic moiety of adenylate cyclase and guanine nucleotide-binding regulatory proteins called G proteins.37 These proteins are from a family of membrane-bound homologous GTP-binding proteins sharing a common heterotrimeric a/3y-subunit structure that transduces stimulatory (Gs) or inhibitory (G1) signals to adenylate cyclase. In myocardium from patients with idiopathic cardiomyopathy, Feldman et a17 observed a 36% increase in the a-subunit of Gi, whereas G, remained unchanged, suggesting that postreceptor inhibitory signals contributed to diminished adrenergic responsiveness. In the canine model of low-output heart failure, the physiological responsiveness to stimulation with Cardiac membranes (2.5 mg/ml) were solubilized in 0.2% Lubrol detergent. After centrifugation, 25, 50, and 100 ,g solubilized membranes and 60 pg cycmembranes were incubated for 20 minutes at 30°C with 10 pM NaF. Adenylate cyclase activity was determined as described in 'Materials and Methods" (n=6 control dogs and n=6 heart failure dogs). dobutamine is markedly impaired. This assessment was made using the contractile response to dobutamine as determined by peak LV +dP/dt. 38, 39 In humans, infusion of dobutamine, a nonselective ,B-agonist with mild a-agonist properties, has been shown to be a useful pharmacological probe of in vivo f3-adrenergic receptor sensitivity.40,4' The advantage of a nonselective ,B-agonist is that it may provide a better approximation of the full P-adrenergic response of the myocardium that depends on both /31and /32-receptors for maximal inotropic response. Heart rate was controlled in the present study by pacing. Although ventricular dimensions were not assessed directly, the responses of arterial pressure and end-diastolic pressure to dobutamine were similar in each state, suggesting that the changes in loading conditions were not a principal determinant of impaired responsiveness. To minimize the cardiovascular effects of anesthesia, the dogs were studied with agents associated with minimal cardiac effects. To further study the mechanisms underlying the decreased /3-adrenergic-mediated functional responsiveness, the ability of isoproterenol to stimulate adenylate cyclase was examined in membranes prepared from both control and failing hearts. Maximal isoproterenol-stimulated adenylate cyclase activity in the failing heart was -40% of that in the controls. Potential mechanisms underlying the decreased P-adrenergic-mediated contractile response in intact dogs and the diminished p-adrenergic-mediated activation of adenylate cyclase in membranes include 1) downregulation of the ,3-receptor, 2) decreased levels of GQ, 3) increased levels of Gi, and 4) defects in the adenylate cyclase itself.
The density of ,3-adrenergic receptors was reduced by 40% in failing canine LV compared with control LV, whereas the affinity for the antagonist [1251]ICYP was unchanged. Subtype analysis revealed a selective decrease in the density of /,-receptors with no change in the density of /,2-receptors. The reduction in density was unlikely to be due to nonspecific changes in the membrane, as neither the density of binding sites for dihydropyridine nor levels of Gp showed differences between control and experimental dogs. The selective downregulation of P,3-receptors is reminiscent of changes described in the failing human heart.' The reduced density of /3-receptors in the membranes from failing dogs was associated with a proportional loss in maximal isoproterenol-stimulated adenylate cyclase activity. G proteins were investigated with several techniques.
The assessment of Gi by immunochemical quantification using antisera and pertussis toxin-catalyzed ADPribosylation labeling revealed modest increases of 34% and 28%, respectively, in failing canine hearts compared with control hearts. Since the pertussis toxinmediated labeling of the Gi-like proteins provides information on the G protein available for ADPribosylation, it has been suggested that the toxin labeling may represent a functional property of the G protein. 37 Nevertheless, the increase in the level of Gi by immunoblotting and enhanced pertussis toxin labeling of the protein suggest an increased amount and/or function of the Gi in membranes of anim failure. At least three isoforms of Gi havi to exist, with the predominant Gi,a in do, and that in humans being Gi, 3.42 Shifts in isoforms of Gia may occur in heart failure. was shown to increase in the failing paced isoform shifts could not be detected with nonspecific antibody nor after pertussis t which measures only the total ribosylatat The functional activity of Gs was asse vitro complementation assay using mer pared from cyc-S49 lymphoma cells th ically deficient in Gs,. The equivalen extracts from failing and normal hearts tute fluoride-stimulated activities sugE levels of GS are similar in the two ty] branes. Immunochemical quantificatio not performed. The possibility remai that in the present study, differential exi by cholate or the influence of extracted than GS may have restored activity an differences in Gs activity.
A defect beyond the ,-receptor was the measurement of adenylate cyclas failing and control dogs in the presen( pharmacological agents. Basal adenylat tivity as well as activity in the presenc and forskolin (without GTP) were sig duced in failing dogs. Since both fluorid lin require G, for maximal adenylate cyc tion, this would imply that levels or func decreased, that there is an increase in G more distally, that there is a defect in moiety of adenylate cyclase itself. Althoi reconstitution suggest normal G, bioacti in G, may in fact still be present. Ther that both fluoride and forskolin stimulh cyclase by a mechanism that is independent of dissociation of af3y-subunits of GQ.343 The defect in the failing canine heart may be manifest only when Gs is I in a heterotrimeric form and not dissociated as occurs during reconstitution. Elevated levels of Gi may also contribute to the enhanced inhibition of Gs and thus of adenylate cyclase.
An abnormality in the catalytic moiety of adenylate cyclase may also contribute to impaired production of cAMP. Evaluation of the catalytic subunit is difficult in crude membranes where contamination with G proteins invariably occurs. In the pressure 0. 8 purified, GTP-y-S-activated G,. The results suggest gs being Gia, that the level of stimulation of adenylate cyclase expression of activity was significantly reduced in the failing myo-Although Gia cardium and strengthen the argument that the activcanine heart, ity of the catalytic subunit is abnormal and indepeni the use of a dent of changes in G proteins.3 toxin labeling,
The alterations in the regulation of cardiac adenyl-)le substrate.
ate cyclase in the pacing model of congestive heart ssed by an in failure differ from those described in the well-studied nbranes pregenetic animal model of cardiac failure, the myoat are genetpathic Syrian hamster. Feldman et a13 and Kessler et t abilities of a145 have shown evidence that decreased bioactivity s to reconstiof the Gs may contribute to the contractile abnormal-;est that the ities seen in this model at an early prenecrotic, pes of memnondilated stage. The Gi and catalytic unit do not n of Gs was appear abnormal. In our canine model, despite obns, however, taining tissue at a late, dilated stage of the disease traction of G.
process when nonspecific responses to heart failure factors other may be evident, we were unable to show evidence of d obliterated altered GS bioactivity. In contrast to the changes found in the Syrian hamster model, we demonstrated evidenced in an impaired Mn2'-stimulated adenylate cyclase activ-,e activity in ity, suggesting a defective catalytic subunit as well as ce of various an increase in the Gia. The mechanism of these te cyclase ac-acquired defects remains unclear. :e of fluoride Changes in the 13-adrenergic complex of the canine ,nificantly re-model of low-output heart failure have multiple le and forskosimilarities to the changes observed in human idioclase stimulapathic cardiomyopathy including 1) a diminished tion of GS are responsiveness to stimulation with /-agonists as asor, perhaps sessed by the contractile response to dobutamine in the catalytic intact animals and by a decreased level of isoprotereugh results of nol-stimulated adenylate cyclase, 2) a selective deivity, a defect crease in fl-adrenergic receptors with a proportional *e is evidence loss of maximal isoproterenol-stimulated adenylate ate adenylate cyclase activity, and 3) postreceptor alterations in-Gsa as measured by in vitro complementation assays.
In contrast to human heart failure, however, the chronically paced canine heart manifests a decreased activity of adenylate cyclase, suggesting a defect in the structure and/or function of the catalytic unit.
In conclusion, this model provides a useful system with which to investigate changes in the f8-receptoradenylate cyclase system using a preparation that is rapidly produced, stable, and free of the pharmacological effects of heart failure therapies that can alter components of the complex and are inherent in studies with human tissue.46 Further studies on the structure and function of the defective catalytic adenylate cyclase are warranted. This initial investigation cannot ascertain whether the change in G proteins or postreceptor alterations was an acquired defect or a nonspecific response to heart failure. In an attempt to elucidate mechanisms by which postreceptor changes occur, studies should be directed at differential tissue expression and developmental regulation of G protein subunits in the failing ventricle at various stages of heart failure development.
